Literature DB >> 28951068

Progress in understanding mucus abnormalities in cystic fibrosis airways.

Jeffrey J Wine1, Gunnar C Hansson2, Peter König3, Nam Soo Joo4, Anna Ermund2, Mario Pieper3.   

Abstract

Normal airways below the carina maintain an essentially sterile environment via a multi-pronged innate defence system that includes mucus clearance via mucociliary clearance and cough, multiple antimicrobials and cellular components including macrophages and neutrophils. In cystic fibrosis (CF), loss of CFTR function compromises these defences, and with present standard of care virtually all people with CF eventually develop mucus accumulation, plugging and chronic infections. This review focuses on how mucus is affected by CFTR loss.
Copyright © 2017 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CF piglet; Cystic fibrosis; Ferret; HCO(3)(–); Hypertonic saline; Microscopic optical coherence tomography; Mucociliary clearance; Mucus; Submucosal glands; β-ENaC transgenic mouse

Mesh:

Substances:

Year:  2017        PMID: 28951068     DOI: 10.1016/j.jcf.2017.09.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  15 in total

1.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

2.  Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis.

Authors:  Carla Cristina Souza Gomez; Paloma Lopes Francisco Parazzi; Karl Jan Clinckspoor; Renan Marrichi Mauch; Francisco Benedito Teixeira Pessine; Carlos Emilio Levy; Andressa Oliveira Peixoto; Maria Ângela Gonçalves Oliveira Ribeiro; Antônio Fernando Ribeiro; Douglas Conrad; Paul Marquis Quinton; Fernando Augusto Lima Marson; José Dirceu Ribeiro
Journal:  Clin Drug Investig       Date:  2020-02       Impact factor: 2.859

Review 3.  Animal models of cystic fibrosis in the era of highly effective modulator therapies.

Authors:  Barbara R Grubb; Alessandra Livraghi-Butrico
Journal:  Curr Opin Pharmacol       Date:  2022-05-13       Impact factor: 4.768

4.  Acidic Submucosal Gland pH and Elevated Protein Concentration Produce Abnormal Cystic Fibrosis Mucus.

Authors:  Yuliang Xie; Lin Lu; Xiao Xiao Tang; Thomas O Moninger; Tony Jun Huang; David A Stoltz; Michael J Welsh
Journal:  Dev Cell       Date:  2020-07-29       Impact factor: 12.270

Review 5.  Pseudomonas aeruginosa and Klebsiella pneumoniae Adaptation to Innate Immune Clearance Mechanisms in the Lung.

Authors:  Sebastian A Riquelme; Danielle Ahn; Alice Prince
Journal:  J Innate Immun       Date:  2018-04-04       Impact factor: 7.349

Review 6.  Advances in gene therapy for cystic fibrosis lung disease.

Authors:  Ziying Yan; Paul B McCray; John F Engelhardt
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 5.121

Review 7.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

Review 8.  Aquaporins in the lung.

Authors:  Oliver H Wittekindt; Paul Dietl
Journal:  Pflugers Arch       Date:  2018-11-05       Impact factor: 3.657

9.  Is PI3K a Villain in Cystic Fibrosis?

Authors:  Viswanathan Natarajan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

10.  Early Lung Disease Exhibits Bacteria-Dependent and -Independent Abnormalities in Cystic Fibrosis Pigs.

Authors:  Drake C Bouzek; Mahmoud H Abou Alaiwa; Ryan J Adam; Alejandro A Pezzulo; Leah R Reznikov; Daniel P Cook; Maria I Aguilar Pescozo; Patrick Ten Eyck; Chaorong Wu; Thomas J Gross; Douglas B Hornick; Eric A Hoffman; David K Meyerholz; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.